Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. (1st March 2020) - Engelina, S.; Saggu, M.; Yoo, J.; Shah, F.; Stevens, A.; Irwin, C.; Chaganti, S.; Scarisbrick, J.J.